EP0777716A2 - Surface-active formulations - Google Patents

Surface-active formulations

Info

Publication number
EP0777716A2
EP0777716A2 EP95929862A EP95929862A EP0777716A2 EP 0777716 A2 EP0777716 A2 EP 0777716A2 EP 95929862 A EP95929862 A EP 95929862A EP 95929862 A EP95929862 A EP 95929862A EP 0777716 A2 EP0777716 A2 EP 0777716A2
Authority
EP
European Patent Office
Prior art keywords
formulation according
component
weight
formulation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95929862A
Other languages
German (de)
French (fr)
Inventor
Laszlo Moldovanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba Spezialitaetenchemie Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba Spezialitaetenchemie Holding AG filed Critical Ciba Geigy AG
Publication of EP0777716A2 publication Critical patent/EP0777716A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0063Photo- activating compounds

Definitions

  • the present invention relates to surface-active formulations as well as to their use for the disinfection and cleansing of the human skin and hands and of hard objects.
  • the surface-active formulations comprise
  • Soap formulations will be understood as meaning aqueous soap solutions which may be obtained as soap or so-called syndet solutions (synthetic detergents).
  • the antimicrobial activity of the novel formulation reaches gram-positive and gram-negative bacteria as well as yeasts, dermatophytes and the like.
  • Suitable components (a) are preferably 2-hydroxydiphenyl ethers, 2-hydroxydiphenyl methanes and 2-hydroxydiphenyl thioethers of the general formula
  • X is oxygen, sulfur or -CH ,
  • Y is chloro or bromo
  • z is S0 2 H, N0 2 or Cj -C 4 alkyl
  • n O or 1.
  • X is oxygen, sulfur or -CH 2 -
  • Y is chloro or bromo
  • r 1 is or 2
  • Component (a) in the novel formulation is preferably used in amounts of 0.02 to 0.2% by weight.
  • C 3 -C 12 di- or polycarboxylic acids typically malonic, succinic, glutaric, adipic, pimelic, suberic, azelaic and sebacic acid, undecanecarboxylic and dodecanedicarboxylic acid, fumaric, maleic, tartaric and malic acid as well as citric and aconitic acid;
  • aminocarboxylic acids typically ethylenediaminetetracetic acid, hydroxyethyl- ethylenediaminetetracetic acid and nitrilotriacetic acid;
  • aromatic carboxylic acids typically benzyl, phenylacetic, phenoxyacetic and cinnamic acid, 2-, 3- and 4-hydroxybenzoic acid, anilinic acid as well as o-, m- and p-chlorophenylacetic acid and o-, m- and p-chlorophenoxyacetic acid;
  • amine salts Rj, R and R 3 have the meaning indicated above;
  • Rj is hydrogen or C ⁇ -C 12 alkyl
  • R 2 and R 3 are each independently of the other hydrogen, C r C 12 alkyl,
  • Rj, R 2 , R 3 and R 4 are each independently of one another hydrogen, Ci-Cgalkyl,
  • C 4 -C 18 aliphatic and monocyclic alcohols typically C -C 18 alkanols, C 2 -C 18 alkenols and teipene alcohols e.g. ethanol, propanol, isopropanol, hexanol, cis-3-hexene-l-ol, trans-2-hexene-l-ol, l-octen-3-ol, heptanol, octanol, trans-2-cis-6-nonadien-l-ol, decanol, linalol, geraniol, dihydroterpineol, myrcenol, nopol and terpineol;
  • Rj, R 2 and R 3 are each independently of one another hydrogen, hydroxy, halogen or C r C 6 alkoxy, typically benzyl alcohol, 2,4-dichlorobenzyl alcohol, phenoxyethanol, l-phenoxy-2-propanol (phenoxyisopropanol) and cinnamyl alcohol;
  • Rj and R 2 are each independently of the other hydrogen, C r C 12 alkyl, C 2 -C 12 alkenyl, Cj-Cgalkanoyl, C 3 -C 18 alkenoyl, R 3 -(OCH-CH 2 -)jT 5 o-, wherein
  • R 3 is hydrogen, C r C 1 alkyl or C ⁇ -C ⁇ alkenyl
  • R 4 is hydrogen or -CH 3 , and -(CH 2 -CH-0) ⁇ 3 ⁇ -CH 2 -CH- .
  • All organic acids mentioned under (b) may also be obtained in the form of their water-soluble salts, such as the alkali metal salts, preferably the sodium or potassium salts or the amine(NR ⁇ R 2 R 3 ) salts, wherein
  • R j , R 2 and R 3 are each independently of one another hydrogen
  • R j , R 2 and R 3 together with the linking nitrogen atom, are unsubstituted or
  • Component (b) can consist of only one compound of subclass (bj) or also of mixtures of one or more than one compound of subclass (b ⁇ ), also together with components of further subclasses. Preferably a combination of one or more than one compound of subclass (bj) and one or more than one compound of subclass (b 2 ) is used.
  • Particularly preferred in this connection is a combination of cumene sulfonate and citric acid monohydrate.
  • Suitable components (c) are anionic, nonionic or zwitterionic and amphoteric synthetic, surface-active substances.
  • Suitable anionic surface-active substances are:
  • - sulfates typically fatty alcohol sulfates, which contain 8 to 18 carbon atoms in the alkyl chain, e.g. sulfated lauryl alcohol;
  • - fatty alcohol ether sulfates typically the acid esters or the salts thereof of a polyadduct of 2 to 30 mol of ethylene oxide with 1 mol of a C 8 -C 22 fatty alcohol;
  • alkali metal salts, ammonium salts or amine salts of C 8 -C 20 f att y acids which are termed soaps, typically coconut fatty acid;
  • alkylamine sulfates typically monoethanolamine lauryl sulfate
  • alkane sulfonates containing 8 to 20 carbon atoms in the alkyl chain, e.g. dodecyl sulfonate;
  • sulfosuccinic acid derivatives typically alkyl sulfosuccinates, alkyl ether sulfosuccinates or alkyl sulfosuccinamide derivatives;
  • X is hydrogen, C r C 4 alkyl or -COO M + ,
  • Y is hydrogen or - alkyl
  • Z is -(CH 2 ) m 1 -
  • ⁇ I is an integer from 6 to 18, and
  • M is an alkali metal ion or an amine ion; alkyl ether carboxylates and alkylaryl ether carboxylates of formula
  • X is a radical
  • R is hydrogen or C j - alkyl, Y i s -(CHCHO T30-,
  • 0-M + A is -(CH ) — COO M + or " y O M + m 2 is 1 to 6, and
  • M is an alkali metal cation or an amine cation.
  • the anionic surfactants used may furthermore be fatty acid methyl taurides, alkylisothionates, fatty acid polypeptide condensates and fatty alcohol phosphoric acid esters.
  • the alkyl radicals in these compounds preferably contain 8 to 24 carbon atoms.
  • the anionic surfactants arc usually obtained in the form of their water-soluble salts, such as the alkali metal, ammonium or amine salts.
  • Typical examples of such salts are lithium, sodium, potassium, ammonium, trie thy lamine, ethanolamine, diethanolamine or triethanolamine salts. It is preferred to use the sodium or potassium salts or the ammonium-(NR ] R 2 R 3 ) salts, wherein R j , R 2 and R 3 are each independently of one another hydrogen, C ⁇ -C 4 alkyl or C r C 4 hydroxyalkyl.
  • Very particularly preferred anionic surfactants in the novel formulation are monoethanolamine lauryl sulfate or the alkali metal salts of fatty alcohol sulfates, preferably the sodium lauryl sulfate and the reaction product of 2 to 4 mol of ethylene oxide and sodium lauryl ether sulfate.
  • Suitable zwitterionic and amphoteric surfactants are C -C 18 betaines, C 8 -C 18 sulfobetaines, C 8 -C 4 alkylamido-C 1 -C alkylenebetaines, imidazoline carboxylates, alkylamphocarboxy carboxylic acids, alkylamphocarboxylic acids (e.g. lauroamphoglycinate) and N-alkyl- ⁇ - aminopropionates or N-alkyl- ⁇ -iminodipropionates. It is preferred to use the C 1 o-C 2 oalkylamido-C 1 -C 4 alkylenebetaines and, more particularly, cocoamidopropylbetaine.
  • Nonionic surfactants are typically derivatives of the adducts of propylene oxide/ethylene oxide having a molecular weight of 1000 to 15000, fatty alcohol ethoxylates (1-50 EO), alkylphenol polyglycol ethers (1-50 EO), ethoxylated carbohydrates, fatty acid glycol partial esters, typically diethylene glycol monostearate, fatty acid alkanolamides and fatty acid dialkanolamides, fatty acid alkanolamide ethoxylates and fatty acid amine oxides.
  • component (c) may furthermore be used the salts of saturated and unsaturated Cg- ⁇ fatty acids, either by themselves, in admixture with each other or in admixture with the other surface-active substances cited for component (c).
  • Illustrative examples of these fatty acids are typically capric, lauric, myristic, palmitic, stearic, arachic, behenic, dodecenoic, tetradecenoic, octadecenoic, oleic, eicosanic and erucic acid, as well as the technical mixtures of such acids, typically coconut fatty acid.
  • acids may be obtained in the form of salts, suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • Suitable components (d) are dihydric alcohols, preferably those containing 2 to 6 carbon atoms in the alkylene radical, typically ethylene glycol, 1,2- or 1,3-propanediol, 1,3-, 1,4- or 2,3-butanediol, 1,5-pentanediol and 1,6-hexanediol. 1,2-propanediol (propylene glycol) is preferred.
  • Component (e) is preferably ethanol, n-propanol and isopropanol, or a mixture of these alcohols. Components (d) and (e) may also be obtained in admixture with each other.
  • the pH of the novel formulation is 3 to 10, preferably 3,5 to 5,5.
  • novel formulations obtained as soap or syndet solutions may additionally comprise customary additives, typically sequestrants, dyes, perfume oils, thickeners or solidifiers (consistency regulators), emollients, UV absorbers, skin-protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, Mg salts of C 1 -C 2 fatty acids and, if desired, preservatives.
  • customary additives typically sequestrants, dyes, perfume oils, thickeners or solidifiers (consistency regulators), emollients, UV absorbers, skin-protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, Mg salts of C 1 -C 2 fatty acids and, if desired, preservatives.
  • Soap formulations of the invention can be prepared by mixing components (a) and (b) and, optionally, (c), (d) and (e), in any order, with the requisite amount of water and stirring the mixture to homogeneity.
  • the mixture is bulked to 100% with mains water or deinonised water. This procedure is a purely physical procedure. Accordingly, there is no chemical reaction of the individual components.
  • the novel soap formulations can be applied thereto in dilute or undilute form, suitably in an amount of at least 2 ml, preferably in the undilute form, for hand disinfection.
  • the invention is illustrated by the following Examples. Parts and percentages are by weight.
  • 0.5 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 4.0 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
  • 1.0 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 4.0 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
  • 0.019 % NaOH are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 9.1 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 9.1.
  • Example 5 Test of the microbicidal activitiv of the novel formulations The microbicidal activity (in decimal logarithms) of the novel formulations according to Examples 1 to 4 is determined with a suspension test. This test is used to assess the bactericidal activity of water-soluble antiseptics, disinfectants and of liquid soaps. The test consists in seeding the test product in selected dilutions with the test bacillus. After a certain contact time, aliquots is taken and the number of surviving bacilli is determined. The difference between the number of the bacilli added and the number of the surviving bacilli is expressed as bacilli reduction in decimal logarithms. The concentration is 90%, the contact time is 30 seconds.

Abstract

The invention relates to surface-active soap formulations, comprising (a) 0.01 to 0.2 % by weight of a microbicidal active substance, (b) 0.1 to 7.5 % by weight of one or more than one hydrotropic agent, (c) 0 to 2 % by weight of one or more than one synthetic surface-active substance or of a soap or of combinations of the cited substances and/or of a salt of a saturated and/or unsaturated C8-C22fatty acid, (d) 0 to 10 % by weight of a dihydric alcohol, (e) 0 to 70 % by weight of a monohydric alcohol, and (f) mains water or deionised water to make up 100 %. The formulation is used for the disinfection and cleansing of the human skin and hands and of hard objects.

Description

Surface-active formulations
The present invention relates to surface-active formulations as well as to their use for the disinfection and cleansing of the human skin and hands and of hard objects.
Special demands of hygiene are not only in hospitals, restaurants or in the food sector, but also in the private sector, as for example in private households or when travelling whereby the demands made upon the disinfectants employed are undoubtedly less stringent in these sectors than in the first-mentioned group. Nonetheless these disinfectants should act within as short a time as possible, and they should preferably be worth the money, have good skin compatibility and be ecologically safe.
Surprisingly, it has now been found that a formulation comprising an extremely low concentration of a microbicidal active substance as well as further components, typically surface-active components, has these properties.
The surface-active formulations comprise
(a) 0.01 to 0.2% by weight of a microbicidal active substance,
(b) 0.1 to 7.5% by weight of one or more than one hydrotropic agent,
(c) 0 to 2% by weight of one or more than one synthetic surface-active substance or of a soap or of combinations of the cited substances and/or of a salt of a saturated and/or unsaturated Cg-C^føtty acid,
(d) 0 to 10% by weight of a dihydric alcohol,
(e) 0 to 70% by weight of a monohydric alcohol, and
(f) mains water or deionised water to make up 100%.
Soap formulations will be understood as meaning aqueous soap solutions which may be obtained as soap or so-called syndet solutions (synthetic detergents).
The antimicrobial activity of the novel formulation reaches gram-positive and gram-negative bacteria as well as yeasts, dermatophytes and the like.
Suitable components (a) are preferably 2-hydroxydiphenyl ethers, 2-hydroxydiphenyl methanes and 2-hydroxydiphenyl thioethers of the general formula
wherein
X is oxygen, sulfur or -CH ,
Y is chloro or bromo, z is S02H, N02 or Cj -C4alkyl,
P is O or 1, n is O or 1.
Of particular interest are compounds of formula (1), wherein
X is oxygen, sulfur or -CH2-, and
Y is chloro or bromo,
r 1 is or 2, and
Of very particular interest are compounds of formula (1), wherein X is oxygen, and Y is chloro, m is O, n is O, o is 1, r is 2, and
P is O.
The compound of formula
is very particularly preferred here.
Component (a) in the novel formulation is preferably used in amounts of 0.02 to 0.2% by weight.
The following compounds are suitable for use as component (b):
(bj): sulfonates, preferably the salts thereof of terpenoids, or mono- or binuclear aromatic compounds, typically sulfonates of camphor, toluene, xylene, cumene or naphthene; (b2): saturated or unsaturated C3-C12di- or polycarboxylic acids, typically malonic, succinic, glutaric, adipic, pimelic, suberic, azelaic and sebacic acid, unde- canedicarboxylic acid and dodecanedicarboxylic acid, fumaric, maleic, tartaric and malic acid as well as citric and aconitic acid; (b3): - aliphatic saturated or unsaturated C^Cnmonocarboxylic acids, typically acetic, propionic, hexanoic, capric or undecylenoic acid;
- saturated or unsaturated C3-C12di- or polycarboxylic acids, typically malonic, succinic, glutaric, adipic, pimelic, suberic, azelaic and sebacic acid, undecanecarboxylic and dodecanedicarboxylic acid, fumaric, maleic, tartaric and malic acid as well as citric and aconitic acid;
- aminocarboxylic acids, typically ethylenediaminetetracetic acid, hydroxyethyl- ethylenediaminetetracetic acid and nitrilotriacetic acid;
- cycloaliphatic carboxylic acids such as camphoric acid;
- aromatic carboxylic acids, typically benzyl, phenylacetic, phenoxyacetic and cinnamic acid, 2-, 3- and 4-hydroxybenzoic acid, anilinic acid as well as o-, m- and p-chlorophenylacetic acid and o-, m- and p-chlorophenoxyacetic acid;
- alkali metal salts and amine salts of inorganic acids, typically the sodium or potassium salts and amineCRjR^) salts of hydrochloric, sulfuric, phosphoric, Cj-Cjoalkylphosphoric acid and boric acid, in which amine salts Rj, R and R3 have the meaning indicated above;
- isethionic acid;
- tannic acid; - acid amides of formula
/ R2
(3) RrCO-N
X R3 wherein
Rj is hydrogen or Cι-C12alkyl, and
R2 and R3 are each independently of the other hydrogen, CrC12alkyl,
C -C12alkenyl, C1-C12hydroxyalkenyl, C2-C12hydroxyalkyl, or a polyglycol ether chain containing 1 to 30 -CH2-CH2-0- or -CHYrCHY2-O- groups, wherein one of the radicals of Yj or Y2 is hydrogen and the other is methyl, e.g.
N-methylacetamide;
- urea derivatives of formula
(4) N-CO-N
' \ D '
R2 R4
wherein
Rj, R2, R3 and R4 are each independently of one another hydrogen, Ci-Cgalkyl,
C -C8alkenyl, -Cghydroxyalkyl or C -C8hydroxyalkenyl;
- monohydric C4-C18aliphatic and monocyclic alcohols, typically C -C18alkanols, C2-C18alkenols and teipene alcohols e.g. ethanol, propanol, isopropanol, hexanol, cis-3-hexene-l-ol, trans-2-hexene-l-ol, l-octen-3-ol, heptanol, octanol, trans-2-cis-6-nonadien-l-ol, decanol, linalol, geraniol, dihydroterpineol, myrcenol, nopol and terpineol;
- aromatic alcohols of formula
wherein
X is -(CHj),^, -CH=CH-CH2-, or -O- CH^^, and
Rj, R2 and R3 are each independently of one another hydrogen, hydroxy, halogen or CrC6alkoxy, typically benzyl alcohol, 2,4-dichlorobenzyl alcohol, phenoxyethanol, l-phenoxy-2-propanol (phenoxyisopropanol) and cinnamyl alcohol;
- polyhydric alcohols and polyhydric alkoxylated, preferably ethoxylated and/or propoxylated alcohols as well as the ethers and esters thereof of the general formula
(6) RrO-X-0-R2,
wherein
Rj and R2 are each independently of the other hydrogen, CrC12alkyl, C2-C12alkenyl, Cj-Cgalkanoyl, C3-C18alkenoyl, R3-(OCH-CH2-)jT5o-, wherein
I
R4
R3 is hydrogen, CrC1 alkyl or C^-C^alkenyl, and R4 is hydrogen or -CH3, and -(CH2-CH-0)τ3ό-CH2-CH- .
CH3 CH3
All organic acids mentioned under (b) may also be obtained in the form of their water-soluble salts, such as the alkali metal salts, preferably the sodium or potassium salts or the amine(NRιR2R3) salts, wherein
Rj, R2 and R3 are each independently of one another hydrogen,
CrC8alkyl, C alkenyl, C1-C8hydroxyalkyl, C5-C8cycloalkyl or polyalkenylenoxy-
CrC18alkyl, or
Rj, R2 and R3, together with the linking nitrogen atom, are unsubstituted or
CrC4alkyl-substituted morpholino.
Component (b) can consist of only one compound of subclass (bj) or also of mixtures of one or more than one compound of subclass (bι ), also together with components of further subclasses. Preferably a combination of one or more than one compound of subclass (bj) and one or more than one compound of subclass (b2) is used.
Particularly preferred in this connection is a combination of cumene sulfonate and citric acid monohydrate.
Suitable components (c) are anionic, nonionic or zwitterionic and amphoteric synthetic, surface-active substances.
Suitable anionic surface-active substances are:
- sulfates, typically fatty alcohol sulfates, which contain 8 to 18 carbon atoms in the alkyl chain, e.g. sulfated lauryl alcohol;
- fatty alcohol ether sulfates, typically the acid esters or the salts thereof of a polyadduct of 2 to 30 mol of ethylene oxide with 1 mol of a C8-C22fatty alcohol;
- the alkali metal salts, ammonium salts or amine salts of C8-C20fatty acids, which are termed soaps, typically coconut fatty acid;
- alkylamide sulfates;
- alkylamine sulfates, typically monoethanolamine lauryl sulfate;
- alkylamide ether sulfates;
- alkylaryl polyether sulfates;
- monoglyceride sulfates;
- alkane sulfonates, containing 8 to 20 carbon atoms in the alkyl chain, e.g. dodecyl sulfonate;
- alkylamide sulfonates;
- alkylaryl sulfonates;
- α-olefin sulfonates;
- sulfosuccinic acid derivatives, typically alkyl sulfosuccinates, alkyl ether sulfosuccinates or alkyl sulfosuccinamide derivatives;
- N-[alkylamidoalkyl]amino acids of formula
/
CH3(CH2)n-CO-N (7) \
CH-Z-COO M+
I X wherein
X is hydrogen, CrC4alkyl or -COO M+,
Y is hydrogen or - alkyl, Z is -(CH2) m 1 -
ΪΪI is an integer from 6 to 18, and
M is an alkali metal ion or an amine ion; alkyl ether carboxylates and alkylaryl ether carboxylates of formula
(8) CH3-X-Y-A ,
wherein
X is a radical ,
R is hydrogen or Cj- alkyl, Y is -(CHCHO T30-,
? 0-M+ A is -(CH ) — COO M+ or " y O M+ m2 is 1 to 6, and
M is an alkali metal cation or an amine cation.
The anionic surfactants used may furthermore be fatty acid methyl taurides, alkylisothionates, fatty acid polypeptide condensates and fatty alcohol phosphoric acid esters. The alkyl radicals in these compounds preferably contain 8 to 24 carbon atoms.
The anionic surfactants arc usually obtained in the form of their water-soluble salts, such as the alkali metal, ammonium or amine salts. Typical examples of such salts are lithium, sodium, potassium, ammonium, trie thy lamine, ethanolamine, diethanolamine or triethanolamine salts. It is preferred to use the sodium or potassium salts or the ammonium-(NR]R2R3) salts, wherein Rj, R2 and R3 are each independently of one another hydrogen, Cι-C4alkyl or CrC4hydroxyalkyl.
Very particularly preferred anionic surfactants in the novel formulation are monoethanolamine lauryl sulfate or the alkali metal salts of fatty alcohol sulfates, preferably the sodium lauryl sulfate and the reaction product of 2 to 4 mol of ethylene oxide and sodium lauryl ether sulfate.
Suitable zwitterionic and amphoteric surfactants are C -C18betaines, C8-C18sulfobetaines, C8-C 4alkylamido-C1-C alkylenebetaines, imidazoline carboxylates, alkylamphocarboxy carboxylic acids, alkylamphocarboxylic acids (e.g. lauroamphoglycinate) and N-alkyl-β- aminopropionates or N-alkyl-β-iminodipropionates. It is preferred to use the C1o-C2oalkylamido-C1-C4alkylenebetaines and, more particularly, cocoamidopropylbetaine.
Nonionic surfactants are typically derivatives of the adducts of propylene oxide/ethylene oxide having a molecular weight of 1000 to 15000, fatty alcohol ethoxylates (1-50 EO), alkylphenol polyglycol ethers (1-50 EO), ethoxylated carbohydrates, fatty acid glycol partial esters, typically diethylene glycol monostearate, fatty acid alkanolamides and fatty acid dialkanolamides, fatty acid alkanolamide ethoxylates and fatty acid amine oxides.
For component (c) may furthermore be used the salts of saturated and unsaturated Cg- ^fatty acids, either by themselves, in admixture with each other or in admixture with the other surface-active substances cited for component (c). Illustrative examples of these fatty acids are typically capric, lauric, myristic, palmitic, stearic, arachic, behenic, dodecenoic, tetradecenoic, octadecenoic, oleic, eicosanic and erucic acid, as well as the technical mixtures of such acids, typically coconut fatty acid. These acids may be obtained in the form of salts, suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines. These salt can also be prepared in situ.
Suitable components (d) are dihydric alcohols, preferably those containing 2 to 6 carbon atoms in the alkylene radical, typically ethylene glycol, 1,2- or 1,3-propanediol, 1,3-, 1,4- or 2,3-butanediol, 1,5-pentanediol and 1,6-hexanediol. 1,2-propanediol (propylene glycol) is preferred.
Component (e) is preferably ethanol, n-propanol and isopropanol, or a mixture of these alcohols. Components (d) and (e) may also be obtained in admixture with each other.
The pH of the novel formulation is 3 to 10, preferably 3,5 to 5,5.
The novel formulations obtained as soap or syndet solutions may additionally comprise customary additives, typically sequestrants, dyes, perfume oils, thickeners or solidifiers (consistency regulators), emollients, UV absorbers, skin-protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, Mg salts of C1 -C 2fatty acids and, if desired, preservatives.
Soap formulations of the invention can be prepared by mixing components (a) and (b) and, optionally, (c), (d) and (e), in any order, with the requisite amount of water and stirring the mixture to homogeneity. The mixture is bulked to 100% with mains water or deinonised water. This procedure is a purely physical procedure. Accordingly, there is no chemical reaction of the individual components.
For disinfection and cleansing of the human skin and hands and of hard objects, the novel soap formulations can be applied thereto in dilute or undilute form, suitably in an amount of at least 2 ml, preferably in the undilute form, for hand disinfection.
The invention is illustrated by the following Examples. Parts and percentages are by weight.
Example 1:
0.075 % 2,4,4,-trichloro-2'-hydroxydiphenyl ether,
0.5 % monoethanolamine laurylsulfate
0.25 % sodium cumene sulfonate powder,
0.4 % citric acid monohydrate, and
0.5 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added. The pH is adjusted to 4.0 with monoethanolamine. Deionised water is then added to the solution to make up a total of 100 parts. The pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
Example 2:
0.25 % 2,4,4'-trichloro-2'-hydroxydiphenyl ether 1.0 % monoethanolamine lauryl sulfate
2.5 % sodium cumene sulfonate powder,
1.5 % citric acid monohydrate, and
1.0 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added. The pH is adjusted to 4.0 with monoethanolamine. Deionised water is then added to the solution to make up a total of 100 parts. The pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
Example 3:
0.15 % 2,4,4'-trichloro-2'-hydroxydiphenyl ether
1.0 % monoethanolamine lauryl sulfate
0.5 % sodium cumene sulfonate powder,
0.8 % citric acid monohydrate, and
5.0 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added. The pH is adjusted to 4.0 with monoethanolamine. Deionised water is then added to the solution to make up a total of 100 parts. The pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
Example 4:
0.1 % 2,4,4,-trichloro-2,-hydroxydiphenyl ether
4.0 % monoethanolamine lauryl sulfate
0.5 % sodium cumene sulfonate powder, and
0.019 % NaOH are stirred to homogeneity and about 90% of the requisite water is then added. The pH is adjusted to 9.1 with monoethanolamine. Deionised water is then added to the solution to make up a total of 100 parts. The pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 9.1.
Example 5: Test of the microbicidal activitiv of the novel formulations The microbicidal activity (in decimal logarithms) of the novel formulations according to Examples 1 to 4 is determined with a suspension test. This test is used to assess the bactericidal activity of water-soluble antiseptics, disinfectants and of liquid soaps. The test consists in seeding the test product in selected dilutions with the test bacillus. After a certain contact time, aliquots is taken and the number of surviving bacilli is determined. The difference between the number of the bacilli added and the number of the surviving bacilli is expressed as bacilli reduction in decimal logarithms. The concentration is 90%, the contact time is 30 seconds.
The following bacilli are used:
Example I 2 3 4
Staph. aureus ATCC 9144 >5.0 >5.0 >5.0 >5.1
Strept. faecalis ATCC 10,541 >5.2 >5.2 >5.2 >5.2
E. Coli ATCC 10,536 4.3 5.1 4.0 *
P. aeruginosa CIP A-22 5.4 >5.4 >5.4
Serratia marcescens ATCC 13,880 * * * >5.4**
* not measured
** contact time 5 minutes
Values above 4 indicate good antimicrobial activity.

Claims

What is claimed is
1. A surface- active surfactant formulation, comprising
(a) 0.01 to 0.2% by weight of a microbicidal active substance,
(b) 0.1 to 7.5% by weight of one or more than one hydrotropic agent,
(c) 0 to 2% by weight of one or more than one synthetic surface- active substance or of a soap or of combinations of the cited substances and/or of a salt of a saturated and/or unsaturated C8-C22fatty acid,
(d) 0 to 10% by weight of a dihydric alcohol,
(e) 0 to 70% by weight of a monohydric alcohol, and
(f) mains water or deionised water to make up 100%.
2. A formulation according to claim 1, wherein component (a) is 2-hydroxydiphenyl ether, 2-hydroxydiphenylmethane and 2-hydroxydiphenyl thioether of the general formula
wherein
X is oxygen, sulfur or -CH2-,
Y is chloro or bromo,
Z is S02H, N02 or CrC4alkyl, r is 0 to 3, o is 0 to 3, p is O or l, m is 0 or 1, and n is O or l.
3. A formulation according to claim 2, wherein the compounds used for component (a) are those of formula (1), wherein
X is oxygen, sulfur or -CH2-, and
Y is chloro or bromo, m is O, n is O or l, o is 1 or 2, r is 1 or 2, and p is O.
4. A formulation according to claim 2 or 3, wherein the compounds used for component (a) are those of formula (1), wherein
X is oxygen, and
Y is chloro, m is O, n is O, o is 1, r is 2, and p is O.
5. A formulation according to claim 4, wherein the compound used for component (a) is that of formula
6. A formulation according to any one of claims 1 to 5, wherein component (a) is used in an amount of 0.02 to 0.2% by weight.
7. A formulation according to any one of claims 1 to 6, wherein component (bj) is a sulfonate, preferably a salt thereof of a terpenoid or of a mono- or binuclear aromatic compound.
8. A formulation according to claim 7, wherein the mono-or binuclear aromatic compound is a sulfonate of camphor, toluene, xylene, cumene or naphthene.
9. A formulation according to claim 7, wherein component (b) consists of only one compound of subclass (bj) or also of a mixture of one or more than one compound of subclass (bj), also with components of further subclasses.
10. A formulation according to any one of claims 1 to 7, wherein component (b) is a combination of one or more than one compound of subclass (bt) and one or more than one compound of subclass (b^.
11. A formulation according to claim 9, wherein a combination of cumene sulfonate and citric acid monohydrate is used.
12. A formulation of any one of claims 1 to 11 , wherein the anionic surfactant is a fatty alcohol sulfate, which contains 8 to 18 carbon atoms in the chain.
13. A formulation according to claim 12, wherein the anionic surfactant is the alkali metal salt of the sulfated lauryl alcohol or of the monoethanolamine lauryl sulfate.
14. A formulation according to any one of claims 1 to 11, wherein component (b) is C1o-C20alkylamido-Ci-C4alkylenebetaine.
15. A formulation according to any one of claims 1 to 14, wherein the salt of a saturated and/or unsaturated -C^fatty acid corresponding to component (c) is selected from the group consisting of lauric, myristic, palmitic, stearic, arachic, behenic, dodecenoic, tetradecenoic, octadecenoic, oleic, eicosanic and erucic acid.
16. A formulation according to any one of claims 1 to 15, wherein component (d) is propylene glycol.
17. A formulation according to any one of claims 1 to 16, wherein component (e) is selected from the group consisting of ethanol, propanol, isopropanol and mixtures of these alcohols.
18. A formulation according to either claim 16 or claim 17, wherein components (d) and (e) are used in admixture with each other.
19. Use of an antimicrobial soap formulation according to any one of claims 1 to 18 for the disinfection and cleansing of the human skin and hands and of hard objects.
20. Use according to claim 19, wherein the antimicrobial soap formulation is in dilute or undilute form.
EP95929862A 1994-08-25 1995-08-14 Surface-active formulations Withdrawn EP0777716A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH261094 1994-08-25
CH2610/94 1994-08-25
PCT/EP1995/003210 WO1996006152A2 (en) 1994-08-25 1995-08-14 Surface-active formulations

Publications (1)

Publication Number Publication Date
EP0777716A2 true EP0777716A2 (en) 1997-06-11

Family

ID=4237644

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95929862A Withdrawn EP0777716A2 (en) 1994-08-25 1995-08-14 Surface-active formulations

Country Status (12)

Country Link
EP (1) EP0777716A2 (en)
JP (1) JPH10504591A (en)
AU (1) AU3345195A (en)
BG (1) BG101306A (en)
BR (1) BR9508767A (en)
CA (1) CA2196774A1 (en)
CZ (1) CZ55597A3 (en)
FI (1) FI970741A (en)
HU (1) HUT77706A (en)
MX (1) MX9701417A (en)
SK (1) SK24597A3 (en)
WO (1) WO1996006152A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2182077T3 (en) 1996-06-04 2003-03-01 Ciba Sc Holding Ag CONCENTRATED LIQUID FORMULATIONS THAT INCLUDE A MICROBICIDALLY ACTIVE INGREDIENT.
ES2184119T3 (en) * 1996-07-10 2003-04-01 Steris Inc TRICLOSAN-BASED SKIN CLEANING PRODUCT WITH IMPROVED EFFECTIVENESS.
BR9603085A (en) * 1996-07-12 1998-05-05 Cosmeticos Natural Ind Com Liquid antiseptic soap for skin care
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
US6861397B2 (en) * 1999-06-23 2005-03-01 The Dial Corporation Compositions having enhanced deposition of a topically active compound on a surface
US6107261A (en) * 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
WO2000078141A1 (en) * 1999-06-23 2000-12-28 The Dial Corporation Antibacterial compositions
BR0011860A (en) * 1999-06-23 2002-04-30 Dial Corp Antibacterial compositions and process for reducing a population of bacteria on a surface
DE19957739A1 (en) * 1999-12-01 2001-06-28 Henkel Ecolab Gmbh & Co Ohg Hand wash lotion for refillable foam generator
EP1167503B1 (en) * 2000-06-21 2006-03-22 Ciba SC Holding AG Surface-active preparations
US8329685B1 (en) 2000-07-19 2012-12-11 North West University Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
EP1341886B1 (en) 2000-12-14 2006-03-08 Ciba SC Holding AG Surface-active compositions
US6616922B2 (en) 2001-03-27 2003-09-09 The Dial Corporation Antibacterial compositions
MXPA03008869A (en) * 2001-03-29 2004-05-24 Dial Corp Antibacterial compositions for skin care.
US6794351B2 (en) 2001-04-06 2004-09-21 Kimberly-Clark Worldwide, Inc. Multi-purpose cleaning articles
AU2002308579B2 (en) * 2001-05-01 2004-07-15 The Dial Corporation Method for reducing malodors in hydrotropic compositions
GB2393907A (en) * 2002-10-12 2004-04-14 Reckitt Benckiser Inc Antimicrobial hard surface cleaner
EP1830638A2 (en) * 2004-12-09 2007-09-12 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
KR20090018120A (en) 2006-06-14 2009-02-19 시바 홀딩 인코포레이티드 Antimicrobial compositions
US20080026974A1 (en) 2006-07-27 2008-01-31 Barnhart Ronald A Antimicrobial hand wash
EP2708593A1 (en) 2012-09-14 2014-03-19 The Procter & Gamble Company Fabric care composition
EP2727991A1 (en) * 2012-10-30 2014-05-07 The Procter & Gamble Company Cleaning and disinfecting liquid hand dishwashing detergent compositions
WO2016172481A1 (en) 2015-04-23 2016-10-27 The Procter & Gamble Company Concentrated personal cleansing compositions and methods
CN107530248B (en) 2015-04-23 2021-03-12 宝洁公司 Concentrated personal cleansing compositions and methods
EP3285725B1 (en) 2015-04-23 2019-12-04 The Procter and Gamble Company Concentrated personal cleansing compositions
MX371306B (en) 2015-04-23 2020-01-24 Procter & Gamble Concentrated personal cleansing compositions and uses.
EP3528777B1 (en) 2016-10-21 2021-09-01 The Procter & Gamble Company Skin cleansing compositions and methods
US11185486B2 (en) 2016-10-21 2021-11-30 The Procter And Gamble Company Personal cleansing compositions and methods
US10806686B2 (en) 2017-02-17 2020-10-20 The Procter And Gamble Company Packaged personal cleansing product
US10675231B2 (en) 2017-02-17 2020-06-09 The Procter & Gamble Company Packaged personal cleansing product

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467619A1 (en) * 1965-11-27 1969-02-13 Henkel & Cie Gmbh Color stable liquid detergents, cleaning agents and dishwashing agents containing disinfectants
GB1266060A (en) * 1969-09-12 1972-03-08
BE768041R (en) * 1971-06-03 1971-12-03 Ciba Geigy Ag COMPOSITION TO FIGHT THE
SE376928B (en) * 1971-12-13 1975-06-16 Basf Wyandotte Corp
GB1539031A (en) * 1975-02-22 1979-01-24 Beecham Group Ltd Pharmaceutical compositions
LU78554A1 (en) * 1977-11-21 1979-06-13 Ciba Geigy Ag PROCESS FOR PRODUCING NEW 3-HYDROXYDIPHENYL ETHERS
DE3117792C2 (en) * 1981-05-06 1990-08-23 Schülke & Mayr GmbH, 2000 Norderstedt The use of an aqueous solution of alcohols, phenols and surfactants as a virucidal agent
DE3723990A1 (en) * 1986-07-23 1988-02-04 Ciba Geigy Ag Microbicidal preparation
BR8900685A (en) * 1988-02-17 1989-10-10 Ciba Geigy Ag COMPOSITION OF ANTIMICROBIAL SOAP AND APPLICATION
US4832861A (en) * 1988-05-27 1989-05-23 Lever Brothers Company Soap compositions of enhanced antimicrobial effectiveness
JPH05279693A (en) * 1992-04-02 1993-10-26 Shin Etsu Chem Co Ltd Antimicrobial detergent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9606152A2 *

Also Published As

Publication number Publication date
CZ55597A3 (en) 1997-06-11
SK24597A3 (en) 1997-08-06
HUT77706A (en) 1998-07-28
WO1996006152A3 (en) 1996-05-02
MX9701417A (en) 1997-05-31
FI970741A0 (en) 1997-02-21
BG101306A (en) 1997-09-30
WO1996006152A2 (en) 1996-02-29
JPH10504591A (en) 1998-05-06
FI970741A (en) 1997-02-21
AU3345195A (en) 1996-03-14
CA2196774A1 (en) 1996-02-29
BR9508767A (en) 1997-11-11

Similar Documents

Publication Publication Date Title
EP0777716A2 (en) Surface-active formulations
EP0777717A2 (en) Surface-active formulations
TW304206B (en)
US8232305B2 (en) Anti-microbial compositions
JP4976184B2 (en) Liquid detergent composition
EP1201229A1 (en) Concentrated liquid formulations comprising a microbicidally active ingredient
NZ321730A (en) Germicidal dishwashing detergent compositions
EP0197968A1 (en) Antiseptic cleansing compositions.
US4456543A (en) Bisbiguanide based antibacterial cleansing products
NZ527650A (en) Preservative blends containing quaternary ammonium compounds
EP0259249A2 (en) Microbicidal preparations
US4835149A (en) Solubilization of salts of pyridine-2-thiol-1-oxide
EP1167503B1 (en) Surface-active preparations
JP5500835B2 (en) Disinfectant / antibacterial composition
EP1551359B1 (en) Surface treatment
CN111246835B (en) Non-soap liquid detergent compositions comprising caprylic acid
JPS6345217A (en) Fungicidal composition
JPH10506116A (en) Use of surfactants to improve the antimicrobial activity of carboxamides
US3355387A (en) Cleansing composition
JP5852843B2 (en) Bactericidal composition
JP2014047275A (en) Detergent composition
GB2242190A (en) Biocidal amines
JPH11180804A (en) Bactericidal composition, acceleration of bactericidal capability and sterilization
PL99061B1 (en) WASHING AND CLEANING AGENT

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970128

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19990702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991113